Author Archive

2022 Biomaterials Science Lectureship awarded to Yizhou Dong

It is with great pleasure that we announce Yizhou Dong (Ohio State University) as the recipient of the 2022 Biomaterials Science lectureship.

This award, now in its ninth year, honours an early-career researcher who has made significant contribution to the biomaterials field. The recipient is selected by the Biomaterials Science Editorial Board from a list of candidates nominated by the community.

Profile picture of Yizhou DongYizhou Dong is an Associate Professor in the Division of Pharmaceutics and Pharmacology, College of Pharmacy at The Ohio State University (OSU). He is also a member of multiple globally recognized research initiatives, such as the Translational Therapeutics Program, the Pelotonia Institute for Immuno-Oncology, the Center for Cancer Engineering, and the Center for Cancer Metabolism at the OSU Comprehensive Cancer Center. Dr. Dong received his B.S. in pharmaceutical sciences from Peking University, Health Science Center and M.S. in organic chemistry from Shanghai Institute of Organic Chemistry. In 2009, he received his Ph.D. degree in pharmaceutical sciences from the University of North Carolina at Chapel Hill (UNC-CH) under the supervision of Professor K.-H. Lee. From 2010 to 2014, he was a postdoctoral fellow in the laboratory of Professors Robert Langer and Daniel Anderson at Harvard Medical School and Massachusetts Institute of Technology.

 

Dr. Dong’s research focuses on the design and development of biotechnology platforms for the treatment of genetic disorders, infectious diseases, and cancers. He has authored over one hundred papers and patents. Several of his inventions have been licensed and are currently under development as drug candidates for clinical trials. Dr. Dong is the recipient of numerous awards, such as the Young Innovator in Cellular and Molecular Bioengineering from the Biomedical Engineering Society, the Maximizing Investigators’ Research Award from the National Institute of General Medical Sciences (NIGMS), the Ohio State Early Career Innovator of the Year, and the American Association of Pharmaceutical Scientists (AAPS) Emerging Leader Award. In 2022, he was elected as a fellow of The American Institute for Medical and Biological Engineering (AIMBE).

 

Read Yizhou’s latest article in Biomaterials Science Harnessing lipid nanoparticles for efficient CRISPR delivery” and his other publications in Biomaterials Science for FREE 22 July. These and articles from our previous lectureship winners can be found in our lectureship winners collection.

 

Read our interview with Yizhou below:

 

How has your research evolved from your first article to this most recent article?

I have been passionate about research in drug discovery and delivery. My first article was in synthetic methodology, which laid a solid foundation for my knowledge and skills in chemical synthesis. In our recent studies, we and our collaborators integrate our specialty in pharmaceutical chemistry, pharmaceutics, biomedical engineering, materials formulation, and animal studies for developing diverse therapeutic medicines.

 

What excites you most about your area of research and what has been the most exciting moment of your career so far?

It is very exciting to see important discoveries in biomaterials and biotechnologies to help understand fundamental sciences and solve real-world problems. I am most excited when I talk with students and postdocs about new ideas to address various medical needs.

 

In your opinion, what are the most important questions to be asked/answered in your field of research? 

What is an effective and efficient strategy to connect preclinical and clinical data? In another word, what types of preclinical results can improve the success rate for clinical translation of experimental agents? On the other hand, could we create a system to better interpret clinical findings and guide the design of next-generation therapeutic agents?

 

How do you feel about Biomaterials Science as a place to publish research on this topic?

Biomaterials Science is a leading journal in the field of biomaterials, which covers broad topics such as molecular design, drug delivery, and biointerface studies. It is a wonderful platform to share new findings and results in Biomaterials Science. Also, the journal offers various opportunities including special issues, blogs, and conferences to authors and readers.

 

Which of your Biomaterials Science publications are you most proud of and why?

We recently published a review article entitled “Harnessing lipid nanoparticles for efficient CRISPR delivery” on Biomaterials Science. With the breakthrough of lipid nanoparticle-mRNA vaccines approved for the prevention of COVID-19, there is more and more research interest in lipid nanoparticles. We are excited to highlight the advances of lipid nanoparticles for genome editing and share our perspectives with broad readers of Biomaterials Science.

 

In which upcoming conferences or events (online or in person) may our readers meet you?

I plan to attend the 32nd Annual Conference of the European Society of Biomaterials in September 2022 at Bordeaux. I look forward to meeting you there.

 

Can you share one piece of career-related advice or wisdom with early career scientists?

There are many challenges in a research career. Be persistent in your research interest.

 

How do you spend your spare time?

I like swimming and reading during my spare time. I also enjoy traveling with family and friends.

 

We would like to thank everybody who nominated a candidate for the 2021 Biomaterials Science Lectureship. The Editorial Board had a very difficult task in choosing a winner from the many excellent and worthy candidates.

 

Please join us in congratulating Yizhou on winning this award!

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

We are very pleased to welcome Professor Nasim Annabi as an Associate Editor for Biomaterials Science

Nasim Annabi is an Assistant Professor in the Department of Chemical and Biomolecular Engineering at University of California, Los Angeles (UCLA). She received a PhD in Chemical Engineering from the University of Sydney. From 2011-2014, she was a postdoctoral fellow at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering. Before joining UCLA in 2018, she was an Assistant Professor in the Department of Chemical Engineering at Northeastern University. Dr. Annabi’s group has expertise in the design and engineering of advanced biomaterials for applications in regenerative medicine. In addition, her research team has devised innovative strategies for the development of advanced bioadhesives and surgical sealants with high clinical translation for surgical applications. Her innovations have resulted in 15 patents and generated significant commercial interest. Dr Annabi has been recognized with several national and international awards including the 2021 Biomaterials Science Lectureship Award, the 2021 Young Investigator Award from the Society for Biomaterials, the 2020 Nanoscale Science and Engineering Forum Young Investigator Award of American Institute of Chemical Engineers, the Australian Prestigious Endeavour Award, and the National Health and Medical Research Council Early Career Award. She can be found on Twitter @nasimannabi.

 

Nasim has given her thoughts and insight on the future of the biomaterials field:

“Recent advances in biomaterials design have created new platforms for engineering innovative medical devices and drug delivery systems for a wide range of therapeutic applications. However, clinical translation of these platforms as reliable and effective technologies remain a challenge. The future of the biomaterials field should focus on merging smart biomaterials with personalized medicine and additive manufacturing to create more effective and safe in vitro platforms for developing drugs and testing medical devices for rapid scale-up and commercialization. The journal Biomaterials Science has successfully integrated various expertise in biological and materials science towards clinical use to create new interdisciplinary domains in the field of biomaterials.”

 

Editor’s Choice: Nasim’s favourite recent Biomaterials Science articles

Here are three publications that Nasim has chosen as her favourite recent articles in Biomaterials Science

 

Nanodot-doped peptide hydrogels for antibacterial phototherapy and wound healing

Xuan Wang, Lin Qiu, Cheng Wang, Zihan Gao, Shuwen Zhou, Pengfei Cui, Pengju Jiang, Huaanzi Hu, Xinye Ni, Xuancheng Du, Jianhao Wang and Jiang Xia

Biomaterials Science, 2022, 10, 654-664

 

3D bio-printed biphasic scaffolds with dual modification of silk fibroin for the integrated repair of osteochondral defects

Changxu Deng, Jin Yang, Hongtao He, Zhenjiang Ma, Wenhao Wang, Yuxin Zhang, Tao Li, Chuanglong He and Jinwu Wang

Biomaterials Science, 2021, 9, 4891-4903

 

 

 

Rational design and latest advances of polysaccharide-based hydrogels for wound healing

Hao Hu and Fu-Jian Xu

Biomaterials Science, 2020, 8, 2084-2101

 

 

 

These articles are all FREE to read until 1 April 2022!

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Introducing the Biomaterials Science Emerging Investigators Series

For many years Biomaterials Science has showcased special collections dedicated to work carried out by researchers in the earlier stages of their research careers in our Emerging Investigator collections, most recently in our 2021 Emerging Investigators collection.

We hope that the biomaterials community has found these issues to be valuable, both in the high quality of the articles and in drawing attention to newer voices in the community. The journal editors and Editorial Board consider these to have been highly successful.

In light of disruption to research programmes worldwide, we have taken the opportunity to reassess the format of this initiative, and we are now excited to announce the launch of the Biomaterials Science Emerging Investigators Series.

 

What is changing?

In place of a dedicated journal issue, Emerging Investigators papers will be published throughout the year. We anticipate the following benefits to this change:

  • No fixed submission deadlines allowing more flexibility for authors
  • Continual exposure of exciting work from early-career members of the community
  • Greater emphasis and focus on individual authors and research groups

We hope for this to offer a better service to our authors and readers well into the future.

 

What is not changing?

While we will no longer dedicate a specific journal issue to our Emerging Investigators, all other aspects of this initiative will remain the same. This includes:

  • Eligibility criteria (see below)
  • A dedicated web page for published articles alongside our other collections
  • Rigour and speed in peer review
  • An overall objective to showcase the full diversity of cutting-edge research carried out from biomaterials scientists in the early stages of their independent careers worldwide

 

What happens now?

The Biomaterials Science Editorial Office will contact nominated Emerging Investigators throughout the year.

Regarding eligibility, contributors must:

  • Publish research within the journal scope
  • Currently be an independent research leader
  • Have not been featured as an Emerging Investigator in a previous Biomaterials Science Emerging Investigators article
  • Have either no more than 12 years of post-PhD research experience in the year of submission when taking into account any career breaks

 

Do you fit the criteria above, and wish to be featured as an Emerging Investigator in the journal? Get in touch with us at biomaterialsscience-rsc@rsc.org

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Call for papers: CRISPR biomaterials

 

Biomaterials Science is delighted to announce a call for papers for its latest themed collection on “CRISPR biomaterials” Guest Edited by Yuan Ping (Zhejiang University), Ming Wang (Institute of Chemistry, Chinese Academy of Sciences) and Qiaobing Xu (Tufts University). 

 

You can access the online collection here to look at the first few contributions to this collection.

 

The shortage of delivery biomaterials that can deliver genome editors and control editing activities represents one of the major challenges for successful CRISPR/Cas-based genome editing. This collection on CRISPR biomaterials seeks to fuel the development in the field of biomaterials for CRISPR/Cas-based genome editing components, and provide a comprehensive overview of the emerging delivery technologies and recent progresses for exploiting biomaterials for CRISPR/Cas systems. We aim to cover the principles of biomacromolecule delivery and gene editing, examine recent advances and challenges in both non-viral and viral delivery methods, and exemplify the status of related applications and clinical trials. The current challenges and future prospects of the delivery technologies for CRISPR system for clinical translations will also discussed.

 

Manuscripts should be submitted via the Royal Society of Chemistry’s online submission service available at https://mc.manuscriptcentral.com/bmsci and let us know by email to biomaterialsscience-rsc@rsc.org. Please add a “note to the editor” in the submission form when you submit your manuscript to say that this is a submission for the themed collection. The Editorial Office reserves the right to check suitability of submissions in relation to the scope of the collection and inclusion of accepted articles in the collection is not guaranteed. Please see our website for more information on journal scope, standards, article types and author guidelines.

 

All manuscripts will be subject to the journal’s usual peer review process. Accepted manuscripts will be added to the online collection as soon as they are online and they will be published in a regular issue of Biomaterials Science.

 

If you have any questions about the journal or the collection, then please do contact the Editorial Office at biomaterialsscience-rsc@rsc.org.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

2022 Biomaterials Science Lectureship – Open for nominations

 Do you know an early-career researcher who deserves recognition for their contribution to the biomaterials field?

 

Biomaterials Science is pleased to announce that nominations are now being accepted for its 2022 Lectureship award and will close on 31 December 2021. This annual award was established in 2014 to honour an early-stage career scientist who has made a significant contribution to the biomaterials field.

 

Biomaterials Science Lectureship open for nominations

 

Eligibility

To be eligible for the lectureship, candidates should meet the following criteria:

  • Be an independent researcher, PhD students postdoctoral research associates are not eligible
  • Be actively pursuing research within the biomaterials field, and have made a significant contribution to the field
  • Be at an early stage of their independent career (this should typically be within 12 years of attaining their doctorate or equivalent degree, but appropriate consideration will be given to those who have taken a career break, work in systems where their time period to independence may vary or who followed an alternative study path)

 

How to nominate

Nominations must be made via email to biomaterialsscience-rsc@rsc.org, and include the following:

  • The name, affiliation and contact details of the nominee, nominator and referee
  • An up-to-date CV of the nominee (1 – 3 A4 page maximum length)
  • A letter of recommendation from the nominator (500 words maximum length)
  • A supporting letter of recommendation from a referee (500 words maximum length). This could be from the nominee’s postdoc, PhD supervisor or academic mentor for instance
  • The nominator must confirm that to the best of their knowledge, their nominee’s professional standing is as such that there is no confirmed or potential impediment to them receiving the Lectureship

Please note:

  • Self-nomination is not permitted
  • The nominee must be aware that he/she has been nominated for this lectureship
  • Previous winners and current Biomaterials Science Editorial Board members are not eligible
  • As part of the Royal Society of Chemistry, we have a responsibility to promote inclusivity and accessibility in order to improve diversity. Where possible, we encourage each nominator to consider nominating candidates of all genders, races, and backgrounds. Please see the RSC’s approach to Inclusion and Diversity.

 

Selection

  • All eligible nominated candidates will be assessed by a judging panel made up of the Biomaterials Science Editorial Board, any Editorial Board members with a conflict of interest will be ineligible for the judging panel.
  • The judging panel will consider the following core criteria:
    • Excellence in research, as evidenced in reference to originality and impact
    • Quality of publications, patents or software
    • Innovation
    • Professional standing
    • Independence
    • Collaborations and teamwork
    • Evidence of promising potential
    • Other indicators of esteem indicated by the nominator
  • In any instance where multiple nominees are judged to be equally meritorious in relation to these core criteria, the judging panel will use information provided on the nominee’s broader contribution to the chemistry community as an additional criterion. Examples of this could include: involvement with RSC community activities, teaching or demonstrating, effective mentorship, service on boards, committees or panels, leadership in the scientific community, peer reviewing, promotion of diversity and inclusion, advocacy for chemistry, public engagement and outreach.

 

Previous winners

2021 – Nasim Annabi, UCLA, USA

2020 – Kanyi Pu, Nanyang Technological University, Singapore

2019 – April Kloxin, University of Delaware, USA

2018 – Zhen Gu, University of North Carolina at Chapel Hill & North Carolina State University, USA

2017 – Zhuang Liu, Soochow University, China

2016 – Fan Yang, Stanford University, USA

2015 – Joel Collier, Duke University, USA

2014 – Suzie Pun, University of Washington, USA

2011 – Michael J. Solomon, University of Michigan, USA

 

Nominations deadline: 31 December 2021

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials Science Emerging Investigator – Arghya Paul

Profile picture of Arghya Paul (black & white)

Arghya Paul is an Associate Professor and Canada Research Chair Tier II in Advanced Cell-Instructive Materials and Biotherapeutics at the University of Western Ontario. Professor Paul received his PhD in Biomedical Engineering from McGill University in 2012 and postdoctoral training at Harvard-MIT Division of Health Sciences and Technology, prior to starting his independent research career in 2014. His research program has been recognized by several awards including Province of Ontario’s Early Research Award (ERA), Wolfe-Western Fellowship, Canada Research Chair, Young Innovator Award from Cellular and Molecular Bioengineering (BMES), Fred Kurata Memorial Professorship. Paul’s Biointel Laboratory at Western focuses on design and development new bioactive materials originating from patient’s own cells, genes, proteins and tissues for diverse biomedical applications, including materials-driven tissue repair and regeneration. He can be found on Twitter @arghya_biointel.

 

Read Arghya’s Emerging Investigator article “Exploiting the role of nanoparticles for use in hydrogel-based bioprinting applications: concept, design, and recent advances” and check out all of the 2021 Biomaterials Science Emerging Investigator articles here.

 

How do you feel about Biomaterials Science as a place to publish research on this topic?

Excellent place to publish high quality papers in the area on biomaterials research that offers high visibility.

Can you share one piece of career-related advice or wisdom with other early career scientists?

Be bold to take strategic risks. Such risks, new opportunities and experiences will help you grow in new directions that your current roles do not offer.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials Science Emerging Investigator – Tianyue Jiang

Profile picture of Tianyue Jiang

Tianyue Jiang obtained her Ph.D. degree in Pharmaceutics under the guidance of Prof. Jianping Zhou in the College of Pharmacy at China Pharmaceutical University. From 2012-2014, she was a visiting scholar in Prof. Zhen Gu’s research group in the Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University. She is currently an associate Professor in the School of Pharmaceutical Sciences at Nanjing Tech University. Her group studies controlled drug delivery, bio-inspired materials and nanobiotechnology.

 

Read Tianyue’s Emerging Investigator article “Topical delivery of chemotherapeutic drugs using nano-hybrid hydrogels to inhibit post-surgical tumour recurrence” and check out all of the 2021 Biomaterials Science Emerging Investigator articles here.

 

How do you feel about Biomaterials Science as a place to publish research on this topic?

The journal is based on the design, function, interaction with the body and related scientific principles of biomaterials, covering the fields of chemistry, biology, pharmacy and materials science, and aims to explore new concepts, designs, functions and applications of biomaterials. I am honored to share my research works.

What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?

My work focuses on the investigation and development of drug delivery systems based on peptide-based materials. Through the arrangement and combination of 20 kinds of natural amino acids and the introduction of exogenous functional groups, we can provide hundreds of millions of peptide molecules. The challenge lies in how to customize peptides with specific functions in a vast array of combinations.

In your opinion, what are the most important questions to be asked/answered in this field of research?

In my opinion, the most important question is how to effectively solve some interdisciplinary problems and technical bottlenecks in my research field of drug delivery.

Can you share one piece of career-related advice or wisdom with other early career scientists?

Maintain enthusiasm and curiosity for scientific research.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials Science Emerging Investigator – Thomas Werfel

Profile picture of Thomas Werfel

Thomas Werfel is Assistant Professor of Biomedical Engineering, Joint Assistant Professor of BioMolecular Sciences, and Affiliate Assistant Professor of Chemical Engineering at The University of Mississippi (UM). Dr. Werfel received his PhD in Biomedical Engineering from Vanderbilt University in 2017, after which he worked as a postdoctoral researcher in Cell and Developmental Biology at Vanderbilt University School of Medicine. In 2018, he joined the Biomedical Engineering Program at the University of Mississippi and is an inaugural faculty member of the Department of Biomedical Engineering at UM – founded in 2019. As a graduate student, Dr. Werfel was awarded the NSF Graduate Research Fellowship Program (GRFP) Fellowship. His tenure as a postdoctoral researcher was supported by the NIH F32 Postdoctoral Fellowship. His research has been published in cross-disciplinary journals from Biomaterials and Advanced Materials to PNAS and Cancer Research, and he was recently recognized as a Biomaterials Science Emerging Investigator in 2021. His research group at UM works at the interface of bioengineering, materials science, and molecular biology to engineer the medicines of the future. He can be found on Twitter @OleMiss_iNBS.

 

Read Thomas’ Emerging Investigator article “Immunostimulatory biomaterials to boost tumor immunogenicity” and check out all of the 2021 Biomaterials Science Emerging Investigator articles here.

 

How do you feel about Biomaterials Science as a place to publish research on this topic?

Biomaterials Science is without doubt a premier worldwide journal to publish broad areas of interdisciplinary research that leverages biomaterials.

What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?

We are most excited about our work to leverage newly-discovered and/or recently characterized immunological processes to boost tumor immunogenicity using targeted, biomaterials-based strategies.

In your opinion, what are the most important questions to be asked/answered in this field of research?

Follow the immunology!! As we continue elucidating the function of the immune system, how can materials be used to modulate these processes toward therapeutic ends?

Can you share one piece of career-related advice or wisdom with other early career scientists?

Establish balance! You always come back refreshed and reinvigorated when you step away for a while – whether a day, a weekend, or a longer vacation.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials Science Emerging Investigator – Evelyn Yim

Profile picture of Evelyn Yim

Evelyn Yim began her education at the University of Toronto, where she earned her BASc in Engineering Science and MASc in Chemical Engineering, under the supervision of Professor Michael Sefton. She pursued her PhD in Biomedical Engineering at Johns Hopkins University before conducting her post-doctoral training at the Johns Hopkins School of Medicine and, under Professor Kam Leong, in the Department of Biomedical Engineering at Duke University. Between 2007 and 2015 Evelyn worked in Singapore, where she held a joint appointment from the National University of Singapore, as faculty in the departments of Biomedical Engineering and Surgery, and the Mechanobiology Institute Singapore, a Research Center of Excellence supported by the National Research Foundation Singapore, as a principle investigator studying how chemical and biomechanical cues influence stem cell behavior. Evelyn Yim joined the University of Waterloo as an Associate Professor in 2016. Evelyn and her Regenerative Nanomedicine Lab group are interested to apply the knowledge biomaterial-stem cell interaction to direct stem cell differentiation and tissue regeneration for neural, vascular and corneal tissue engineering.

 

Read Evelyn’s Emerging Investigator article “Enhanced efficiency of nonviral direct neuronal reprogramming on topographical patterns” and check out all of the 2021 Biomaterials Science Emerging Investigator articles here.

 

What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?

Excited: the field is moving very fast with a lot of new analytical technologies available

Challenging: getting funding.

In your opinion, what are the most important questions to be asked/answered in this field of research?

I think the mechanism of cell-materials interaction, including immune response and mechanobiology, is very important.

Can you share one piece of career-related advice or wisdom with other early career scientists?

Try your best! But remember to keep a good work-life balance.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials Science Emerging Investigator – Sidi Bencherif

Profile picture of Sidi Bencherif

Sidi A. Bencherif received two Master’s degrees in Physical Sciences (2000) and then in Materials Science and Engineering (2002) from the University of Montpellier in France. In 2002, he worked for 3 years as a guest researcher at the US National Institute of Standards and Technology (NIST). In 2009, he received a Master’s degree in Polymer Science and a PhD degree in Chemistry from Carnegie Mellon University. In 2009, he joined as a postdoctoral fellow the laboratory of David Mooney at Harvard University and has been appointed as an Assistant Professor of Chemical Engineering at Northeastern University since 2016. He can be found on Twitter @bencheriflab.

 

Read Sidi’s Emerging Investigator article “Engineering a macroporous fibrin-based sequential interpenetrating polymer network for dermal tissue engineering” which was featured on the front cover, and check out all of the 2021 Biomaterials Science Emerging Investigator articles here.

 

How do you feel about Biomaterials Science as a place to publish research on this topic?

I feel that Biomaterials Science is an outstanding journal to read about the latest advances in biomaterials research and to publish our work. Biomaterials Science is among one of the few journals where I find the most interdisciplinary and interesting work on biomaterials, tissue engineering, immunoengineering, and beyond.

What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?

Currently, I am most excited about engineering advanced biomaterials to manipulate the fate of mammalian cells, especially immune cells. A challenge in this work is to control the extent of immunostimulation while achieving a beneficial outcome in a safe but also sustained and consistent fashion.

Can you share one piece of career-related advice or wisdom with other early-career scientists?

One piece of advice I have for other early career scientists is to not be afraid of failure. Many things you try won’t work, but that’s ok. We learn more from failure than from getting something right on the first try. Don’t be discouraged but rather learn from those mistakes, keep working as hard as you can, and everything is going to be all right.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)